| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Allergy and Infectious Diseases (NIAID) |
| Information provided by: | National Institute of Allergy and Infectious Diseases (NIAID) |
| ClinicalTrials.gov Identifier: | NCT00183287 |
Purpose
The purpose of this study is to monitor the progression of HIV infection and HIV-related disease processes in patients who have previously participated in HIV clinical trials.
| Condition |
|
HIV Infections |
| MedlinePlus related topics: | AIDS |
| Study Type: | Observational |
| Study Design: | Case-Only, Prospective |
| Official Title: | Clinical, Virologic, and Immunologic Evaluation and Monitoring of Patients With Known or Suspected HIV Infection |
Blood collection
| Estimated Enrollment: | 150 |
| Study Start Date: | September 2009 |
| Estimated Primary Completion Date: | September 2010 (Final data collection date for primary outcome measure) |
Since 1982, the National Institute of Allergy and Infectious Diseases (NIAID) has been conducting numerous clinical trials on patients infected with HIV-1. Unfortunately, once clinical studies have closed or participants have reached a study endpoint, no additional follow-up data are collected regarding progression of HIV infection and development of HIV-related complications in these study participants. This study will collect long-term data for participants of previous NIAID-sponsored clinical trials to study HIV-related disease processes and complications, benefits and toxicities of investigational medications and vaccines, and medical management of participants with known or suspected HIV infection.
Study visits will occur every 6 months. A physical exam, blood collection, and medical history will occur at all visits. Depending on the need of participants, additional laboratory and diagnostic tests will be performed, and standard medical care will be provided.
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
HIV-infected individuals who have previously participated in NIAID-funded HIV clinical trials
Inclusion Criteria:
Contacts and Locations More Information
Haga clic aquí para ver información sobre este ensayo clínico en español.
|
| Responsible Party: | DAIDS ( Rona Siskind ) |
| Study ID Numbers: | IRP 020 |
| First Received: | September 13, 2005 |
| Last Updated: | September 25, 2008 |
| ClinicalTrials.gov Identifier: | NCT00183287 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
